| Code | Display | Definition |
| A | ALIMENTARY TRACT AND METABOLISM | |
| A01 | STOMATOLOGICAL PREPARATIONS | |
| A01A | STOMATOLOGICAL PREPARATIONS | |
| A01AA | Caries prophylactic agents | |
| A01AA01 | sodium fluoride | |
| A01AA02 | sodium monofluorophosphate | |
| A01AA03 | olaflur | |
| A01AA04 | stannous fluoride | |
| A01AA30 | combinations | |
| A01AA51 | sodium fluoride, combinations | |
| A01AB | Antiinfectives and antiseptics for local oral treatment | |
| A01AB02 | hydrogen peroxide | |
| A01AB03 | chlorhexidine | |
| A01AB04 | amphotericin B | |
| A01AB05 | polynoxylin | |
| A01AB06 | domiphen | |
| A01AB07 | oxyquinoline | |
| A01AB08 | neomycin | |
| A01AB09 | miconazole | |
| A01AB10 | natamycin | |
| A01AB11 | various | |
| A01AB12 | hexetidine | |
| A01AB13 | tetracycline | |
| A01AB14 | benzoxonium chloride | |
| A01AB15 | tibezonium iodide | |
| A01AB16 | mepartricin | |
| A01AB17 | metronidazole | |
| A01AB18 | clotrimazole | |
| A01AB19 | sodium perborate | |
| A01AB21 | chlortetracycline | |
| A01AB22 | doxycycline | |
| A01AB23 | minocycline | |
| A01AC | Corticosteroids for local oral treatment | |
| A01AC01 | triamcinolone | |
| A01AC02 | dexamethasone | |
| A01AC03 | hydrocortisone | |
| A01AC54 | prednisolone, combinations | |
| A01AD | Other agents for local oral treatment | |
| A01AD01 | epinephrine | |
| A01AD02 | benzydamine | |
| A01AD05 | acetylsalicylic acid | |
| A01AD06 | adrenalone | |
| A01AD07 | amlexanox | |
| A01AD08 | becaplermin | |
| A01AD11 | various | |
| A02 | DRUGS FOR ACID RELATED DISORDERS | |
| A02A | ANTACIDS | |
| A02AA | Magnesium compounds | |
| A02AA01 | magnesium carbonate | |
| A02AA02 | magnesium oxide | |
| A02AA03 | magnesium peroxide | |
| A02AA04 | magnesium hydroxide | |
| A02AA05 | magnesium silicate | |
| A02AA10 | combinations | |
| A02AB | Aluminium compounds | |
| A02AB01 | aluminium hydroxide | |
| A02AB02 | algeldrate | |
| A02AB03 | aluminium phosphate | |
| A02AB04 | dihydroxialumini sodium carbonate | |
| A02AB05 | aluminium acetoacetate | |
| A02AB06 | aloglutamol | |
| A02AB07 | aluminium glycinate | |
| A02AB10 | combinations | |
| A02AC | Calcium compounds | |
| A02AC01 | calcium carbonate | |
| A02AC02 | calcium silicate | |
| A02AC10 | combinations | |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | |
| A02AD01 | ordinary salt combinations | |
| A02AD02 | magaldrate | |
| A02AD03 | almagate | |
| A02AD04 | hydrotalcite | |
| A02AD05 | almasilate | |
| A02AF | Antacids with antiflatulents | |
| A02AF01 | magaldrate and antiflatulents | |
| A02AF02 | ordinary salt combinations and antiflatulents | |
| A02AG | Antacids with antispasmodics | |
| A02AH | Antacids with sodium bicarbonate | |
| A02AX | Antacids, other combinations | |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
| A02BA | H2-receptor antagonists | |
| A02BA01 | cimetidine | |
| A02BA02 | ranitidine | |
| A02BA03 | famotidine | |
| A02BA04 | nizatidine | |
| A02BA05 | niperotidine | |
| A02BA06 | roxatidine | |
| A02BA07 | ranitidine bismuth citrate | |
| A02BA08 | lafutidine | |
| A02BA51 | cimetidine, combinations | |
| A02BA53 | famotidine, combinations | |
| A02BB | Prostaglandins | |
| A02BB01 | misoprostol | |
| A02BB02 | enprostil | |
| A02BC | Proton pump inhibitors | |
| A02BC01 | omeprazole | |
| A02BC02 | pantoprazole | |
| A02BC03 | lansoprazole | |
| A02BC04 | rabeprazole | |
| A02BC05 | esomeprazole | |
| A02BC06 | dexlansoprazole | |
| A02BC07 | dexrabeprazole | |
| A02BC53 | lansoprazole, combinations | |
| A02BC54 | rabeprazole, combinations | |
| A02BD | Combinations for eradication of Helicobacter pylori | |
| A02BD01 | omeprazole, amoxicillin and metronidazole | |
| A02BD02 | lansoprazole, tetracycline and metronidazole | |
| A02BD03 | lansoprazole, amoxicillin and metronidazole | |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin | |
| A02BD05 | omeprazole, amoxicillin and clarithromycin | |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin | |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin | |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole | |
| A02BD09 | lansoprazole, clarithromycin and tinidazole | |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin | |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin | |
| A02BD13 | rabeprazole, amoxicillin and metronidazole | |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin | |
| A02BD15 | vonoprazan, amoxicillin and metronidazole | |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
| A02BX01 | carbenoxolone | |
| A02BX02 | sucralfate | |
| A02BX03 | pirenzepine | |
| A02BX04 | methiosulfonium chloride | |
| A02BX05 | bismuth subcitrate | |
| A02BX06 | proglumide | |
| A02BX07 | gefarnate | |
| A02BX08 | sulglicotide | |
| A02BX09 | acetoxolone | |
| A02BX10 | zolimidine | |
| A02BX11 | troxipide | |
| A02BX12 | bismuth subnitrate | |
| A02BX13 | alginic acid | |
| A02BX14 | rebamipide | |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics | |
| A02BX71 | carbenoxolone, combinations with psycholeptics | |
| A02BX77 | gefarnate, combinations with psycholeptics | |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group | |
| A03AA01 | oxyphencyclimine | |
| A03AA03 | camylofin | |
| A03AA04 | mebeverine | |
| A03AA05 | trimebutine | |
| A03AA06 | rociverine | |
| A03AA07 | dicycloverine | |
| A03AA08 | dihexyverine | |
| A03AA09 | difemerine | |
| A03AA30 | piperidolate | |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds | |
| A03AB01 | benzilone | |
| A03AB02 | glycopyrronium bromide | |
| A03AB03 | oxyphenonium | |
| A03AB04 | penthienate | |
| A03AB05 | propantheline | |
| A03AB06 | otilonium bromide | |
| A03AB07 | methantheline | |
| A03AB08 | tridihexethyl | |
| A03AB09 | isopropamide | |
| A03AB10 | hexocyclium | |
| A03AB11 | poldine | |
| A03AB12 | mepenzolate | |
| A03AB13 | bevonium | |
| A03AB14 | pipenzolate | |
| A03AB15 | diphemanil | |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | |
| A03AB17 | tiemonium iodide | |
| A03AB18 | prifinium bromide | |
| A03AB19 | timepidium bromide | |
| A03AB21 | fenpiverinium | |
| A03AB53 | oxyphenonium, combinations | |
| A03AC | Synthetic antispasmodics, amides with tertiary amines | |
| A03AC02 | dimethylaminopropionylphenothiazine | |
| A03AC04 | nicofetamide | |
| A03AC05 | tiropramide | |
| A03AD | Papaverine and derivatives | |
| A03AD01 | papaverine | |
| A03AD02 | drotaverine | |
| A03AD30 | moxaverine | |
| A03AE | Serotonin receptor antagonists | |
| A03AE01 | alosetron | |
| A03AE03 | cilansetron | |
| A03AX | Other drugs for functional gastrointestinal disorders | |
| A03AX01 | fenpiprane | |
| A03AX02 | diisopromine | |
| A03AX03 | chlorbenzoxamine | |
| A03AX04 | pinaverium | |
| A03AX05 | fenoverine | |
| A03AX06 | idanpramine | |
| A03AX07 | proxazole | |
| A03AX08 | alverine | |
| A03AX09 | trepibutone | |
| A03AX10 | isometheptene | |
| A03AX11 | caroverine | |
| A03AX12 | phloroglucinol | |
| A03AX13 | silicones | |
| A03AX14 | valethamate | |
| A03AX30 | trimethyldiphenylpropylamine | |
| A03AX58 | alverine, combinations | |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN | |
| A03BA | Belladonna alkaloids, tertiary amines | |
| A03BA01 | atropine | |
| A03BA03 | hyoscyamine | |
| A03BA04 | belladonna total alkaloids | |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | |
| A03BB01 | butylscopolamine | |
| A03BB02 | methylatropine | |
| A03BB03 | methylscopolamine | |
| A03BB04 | fentonium | |
| A03BB05 | cimetropium bromide | |
| A03BB06 | homatropine methylbromide | |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics | |
| A03CA01 | isopropamide and psycholeptics | |
| A03CA02 | clidinium and psycholeptics | |
| A03CA03 | oxyphencyclimine and psycholeptics | |
| A03CA04 | otilonium bromide and psycholeptics | |
| A03CA05 | glycopyrronium bromide and psycholeptics | |
| A03CA06 | bevonium and psycholeptics | |
| A03CA07 | ambutonium and psycholeptics | |
| A03CA08 | diphemanil and psycholeptics | |
| A03CA09 | pipenzolate and psycholeptics | |
| A03CA30 | emepronium and psycholeptics | |
| A03CA34 | propantheline and psycholeptics | |
| A03CB | Belladonna and derivatives in combination with psycholeptics | |
| A03CB01 | methylscopolamine and psycholeptics | |
| A03CB02 | belladonna total alkaloids and psycholeptics | |
| A03CB03 | atropine and psycholeptics | |
| A03CB04 | methylhomatropine and psycholeptics | |
| A03CB31 | hyoscyamine and psycholeptics | |
| A03CC | Other antispasmodics in combination with psycholeptics | |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | |
| A03DA | Synthetic anticholinergic agents in combination with analgesics | |
| A03DA01 | tropenzilone and analgesics | |
| A03DA02 | pitofenone and analgesics | |
| A03DA03 | bevonium and analgesics | |
| A03DA04 | ciclonium and analgesics | |
| A03DA05 | camylofin and analgesics | |
| A03DA06 | trospium and analgesics | |
| A03DA07 | tiemonium iodide and analgesics | |
| A03DB | Belladonna and derivatives in combination with analgesics | |
| A03DB04 | butylscopolamine and analgesics | |
| A03DC | Other antispasmodics in combination with analgesics | |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination | |
| A03ED | Antispasmodics in combination with other drugs | |
| A03F | PROPULSIVES | |
| A03FA | Propulsives | |
| A03FA01 | metoclopramide | |
| A03FA02 | cisapride | |
| A03FA03 | domperidone | |
| A03FA04 | bromopride | |
| A03FA05 | alizapride | |
| A03FA06 | clebopride | |
| A03FA07 | itopride | |
| A03FA08 | cinitapride | |
| A03FA09 | mosapride | |
| A04 | ANTIEMETICS AND ANTINAUSEANTS | |
| A04A | ANTIEMETICS AND ANTINAUSEANTS | |
| A04AA | Serotonin (5HT3) antagonists | |
| A04AA01 | ondansetron | |
| A04AA02 | granisetron | |
| A04AA03 | tropisetron | |
| A04AA04 | dolasetron | |
| A04AA05 | palonosetron | |
| A04AA55 | palonosetron, combinations | |
| A04AD | Other antiemetics | |
| A04AD01 | scopolamine | |
| A04AD02 | cerium oxalate | |
| A04AD04 | chlorobutanol | |
| A04AD05 | metopimazine | |
| A04AD10 | dronabinol | |
| A04AD11 | nabilone | |
| A04AD12 | aprepitant | |
| A04AD13 | casopitant | |
| A04AD14 | rolapitant | |
| A04AD51 | scopolamine, combinations | |
| A04AD54 | chlorobutanol, combinations | |
| B | BLOOD AND BLOOD FORMING ORGANS | |
| C | CARDIOVASCULAR SYSTEM | |
| C10 | LIPID MODIFYING AGENTS | |
| C10A | LIPID MODIFYING AGENTS, PLAIN | |
| C10AA | HMG CoA reductase inhibitors | |
| C10AA01 | simvastatin | |
| D | DERMATOLOGICALS | |
| G | GENITO URINARY SYSTEM AND SEX HORMONES | |
| G02 | OTHER GYNECOLOGICALS | |
| G02C | OTHER GYNECOLOGICALS | |
| G02CX | Other gynecologicals | |
| G02CX04 | Cimicifugae rhizoma | |
| H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | |
| J | ANTIINFECTIVES FOR SYSTEMIC USE | |
| J07 | VACCINES | |
| J07C | BACTERIAL AND VIRAL VACCINES, COMBINED | |
| J07CA | Bacterial and viral vaccines, combined | |
| J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus | |
| L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | |
| L02 | ENDOCRINE THERAPY | |
| L02B | HORMONE ANTAGONISTS AND RELATED AGENTS | |
| L02BG | Aromatase inhibitors | |
| L02BG03 | anastrozole | |
| M | MUSCULO-SKELETAL SYSTEM | |
| N | NERVOUS SYSTEM | |
| N02 | ANALGESICS | |
| N02A | OPIOIDS | |
| N02AA | Natural opium alkaloids | |
| N02AA01 | morphine | |
| N02AA02 | opium | |
| N02AA03 | hydromorphone | |
| N02AA04 | nicomorphine | |
| N02AA05 | oxycodone | |
| N02AA08 | dihydrocodeine | |
| N02AA10 | papaveretum | |
| N02AA51 | morphine, combinations | |
| N02AA53 | hydromorphone and naloxone | |
| N02AA55 | oxycodone and naloxone | |
| N02AA56 | oxycodone and naltrexone | |
| N02AA58 | dihydrocodeine, combinations | |
| N02AA59 | codeine, combinations excl. psycholeptics | |
| N02AA79 | codeine, combinations with psycholeptics | |
| N03 | ANTIEPILEPTICS | |
| N03A | ANTIEPILEPTICS | |
| N03AA | Barbiturates and derivatives | |
| N03AA01 | methylphenobarbital | |
| N03AA02 | phenobarbital | |
| N03AA03 | primidone | |
| N03AA04 | barbexaclone | |
| N03AA30 | metharbital | |
| P | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | |
| R | RESPIRATORY SYSTEM | |
| S | SENSORY ORGANS | |
| V | VARIOUS | |